U.S. Federal Trade Commission (FTC) · United States
FTC Health Product Compliance Guidance
Health, safety and efficacy claims for supplements, OTC drugs, health devices and wellness products must be backed by competent and reliable scientific evidence, generally human clinical trials of the product, and non-drug products must not claim to treat or cure disease.
Health, safety and efficacy claims for supplements, OTC drugs, health devices and wellness products must be backed by competent and reliable scientific evidence, generally human clinical trials of the product, and non-drug products must not claim to treat or cure disease. Ads, websites, emails and social posts making health or efficacy claims for supplements, OTC drugs, functional foods, health devices
Health, safety and efficacy claims for supplements, OTC drugs, health devices and wellness products must be backed by competent and reliable scientific evidence, generally human clinical trials of the product, and non-drug products must not claim to treat or cure disease.
How can marketing teams comply?
Ads, websites, emails and social posts making health or efficacy claims for supplements, OTC drugs, functional foods, health devices and wellness programs.
Health, safety and efficacy claims for supplements, OTC drugs, health devices and wellness products must be backed by competent and reliable scientific evidence, generally human clinical trials of the product, and non-drug products must not claim to treat or cure disease.
The FTC requires food and beverage health and nutrition advertising claims to be truthful, not misleading and backed by competent and reliable scientific evidence, applying FDA labeling definitions as a benchmark.
Ads for OTC homeopathic drugs that make efficacy claims must convey that there is no scientific evidence the product works and that the claims rest only on 1700s homeopathic theories most modern experts reject.
Sexual wellness advertising must be truthful and substantiated: non-drug products may not claim to treat sexual disorders or match prescription drugs, and enlargement, performance and safety claims must not be deceptive.
Under FTC Act Section 5 and the VIZIO case, smart TV and streaming services must clearly disclose that they collect viewing data and share it, and get consent before collecting; privacy claims must not be misleading.
CARU's self-regulatory guidelines require ads directed at children under 13 to be clearly identified as ads, show products truthfully, avoid pressure tactics and unsafe depictions, and make purchase costs clear.
The FTC Act bars deceptive advertising: objective claims need a reasonable basis before they run, and qualifications and material terms must be clear and conspicuous so the net impression is not misleading.
Request a free compliance scan of your homepage and book a time with Warrant.